An approach to attract and capture elusive immune disease cells in vivo


T cells, a subtype of white blood cells, play key roles in cell-mediated immunity, be it to fight infections and cancer or, when corrupted, to react against the body’s own cells in more than 80 autoimmune diseases, including type I diabetes, multiple sclerosis, rheumatoid arthritis and others.

However, isolating disease-related T cells from the body to better study or eliminate them poses a formidable challenge to researchers and clinicians.

Wyss Institute researchers are generating implantable and injectable biomaterials to concentrate and trap disease-related T cells.

To this end, and for a limited period of time, they place porous scaffolds with biological components under the skin.

These spiked scaffolds can attract and ‘trap’ circulating T cells that after retrieval of the biomaterial can be easily isolated. Using this approach, researchers can get access to disease specific autoreactive T cells to study and better understand their detrimental functions.




They can even deploy their T cell traps to potentially reduce the number of tissue-damaging T cells therapeutically, or ask how drugs affect disease-specific T cell populations in patients.

These T cell traps could give us a handle on autoreactive T cell populations in different autoimmune diseases and be used as a read-out for the drugs that may actually raise immune tolerance in these disorders.

The Wyss team provided proof-of-concept for the method by applying it to animal models of human type I diabetes and isolating diabetes-promoting T cell populations.

Wyss researchers are also expanding the use of T cell traps to capture T cells with pivotal roles in other than autoimmune diseases which will enable them to study their functions or exploit them therapeutically.


Please enter your comment!
Please enter your name here

Questo sito usa Akismet per ridurre lo spam. Scopri come i tuoi dati vengono elaborati.